Related Experiment Video
Updated: Jun 21, 2025

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
Securement to Prevent Noncuffed Central Venous Catheter Dislodgement in Pediatrics: The SECURED Superiority
Tricia M Kleidon1,2,3,4, Jessica Schults2,5, Victoria Gibson1,2,3,4
1Children's Health Queensland Hospital and Health Service, Brisbane, Australia.
Insights
The subcutaneous anchor securement system (SASS) significantly reduced central venous catheter (CVC) dislodgement in children compared to sutureless securement devices (SSDs). This innovative approach offers a safer and more cost-effective solution for pediatric CVC care.
Area of Science:
- Pediatric critical care medicine
- Vascular access device management
- Medical device security
Background:
- Catheter dislodgement is a frequent complication in pediatric patients with central venous catheters (CVCs).
- Traditional securement methods may not always prevent accidental dislodgement, leading to potential patient harm and increased healthcare costs.
- The subcutaneous anchor securement system (SASS) presents a novel approach to enhance CVC stability.
Purpose of the Study:
- To compare the incidence of dislodgement between noncuffed CVCs secured with SASS and those secured with sutureless securement devices (SSDs).
- To evaluate the safety and cost-effectiveness of SASS compared to SSDs in a pediatric population.
Main Methods:
- A pragmatic, multicenter, superiority randomized clinical trial (SECURED trial) involving pediatric patients aged 0-18 years requiring noncuffed CVCs.
- Patients were randomized 1:1 to receive either SASS or SSD securement for 8 weeks or until device removal.
- Dislodgement was defined as catheter tip movement >1 cm, analyzed using generalized linear models.
Main Results:
- SASS significantly reduced CVC dislodgement rates (5.2%) compared to SSDs (22.7%) (RR, 0.23; P < .001).
- Fewer complications were observed with SASS securement (24.2% vs. 39.0%).
- SASS resulted in lower per-participant healthcare costs (US $24.36) despite increased removal difficulty.
Conclusions:
- The subcutaneous anchor securement system (SASS) is superior to sutureless securement devices (SSDs) in preventing dislodgement of noncuffed central venous catheters in children.
- SASS demonstrates an acceptable safety profile and offers significant cost savings.
- Implementation of SASS at a health service level is recommended for improved pediatric CVC care.
Importance:
Catheter dislodgement is a common complication for children with tunneled or peripherally inserted noncuffed central venous catheters (CVCs). A subcutaneous anchor securement system (SASS) may reduce this risk compared with traditional adhesive securement.
Objective:
To compare dislodgement of noncuffed CVCs secured with SASS with dislodgement of noncuffed CVCs secured with sutureless securement devices (SSDs).
Design, Setting, And Participants:
The SECURED (Securing Central Venous Catheters to Prevent Dislodegment) trial was a pragmatic, multicenter, superiority randomized clinical trial with an internal pilot and was conducted from August 5, 2020, to August 30, 2022, at 2 Australian quaternary pediatric hospitals. Data analysis was performed in January 2023. Patients aged 0 to 18 years requiring a noncuffed CVC (≥3F catheter) were eligible for inclusion. Follow-up duration was 8 weeks or until device removal.
Interventions:
Patients were randomly assigned 1:1 to receive an SASS or SSD, stratified by hospital and catheter type. Only 1 catheter was studied per patient.
Main Outcomes And Measures:
The primary outcome was dislodgement (partial or total), defined as movement of the catheter tip by greater than 1 cm (change in external catheter length) at any point during catheter dwell. Dislodgement, reported as a risk ratio (RR), was estimated using a generalized linear model with binomial family and log link. Secondary outcomes were reported as incidence rate ratios and were analyzed using Poission regression. Outcomes reported as mean differences (MDs) were analyzed using linear regression.
Results:
Of 310 randomized patients, 175 patients (56.5%) were male and median (IQR) patient age was 48 (16-120) months. A total of 307 patients had a catheter device inserted, of which 153 (49.8%) were SASS and 154 (50.2%) were SSD, and were included in the intention-to-treat (ITT) analysis. Device dislodgement was lower with SASS (8 dislodgements in 153 patients [5.2%]) compared with SSD (35 dislodgements in 154 patients [22.7%]) (RR, 0.23; 95% CI, 0.11-0.48; P < .001). The per-protocol analysis was consistent with the ITT analysis. Partial dislodgement accounted for most dislodgement events, including 6 partial dislodgements in the SASS group (3.9%) and 30 partial dislodgements in the SSD group (19.5%) (RR, 0.18; 95% CI, 0.08-0.42). This contributed to fewer complications during dwell in the SASS group (37 reported complications [24.2%]) vs the SSD group (60 reported complications [39.0%]) (RR, 0.62; 95% CI, 0.44-0.87). Staff reported greater difficulty removing devices anchored with SASS vs SSD (mean [SD], 29.1 [31.3] vs 5.3 [17.0], respectively; MD, 23.8; 95% CI, 16.7-31.0). However, use of SASS resulted in reduced per-participant health care costs of A$36.60 (95% credible interval, 4.25-68.95; US $24.36; 95% credible interval, 2.83-45.89).
Conclusions And Relevance:
In the SECURED trial, noncuffed CVCs secured with SASS had fewer dislodgements compared with SSDs, with a lower cost per patient and an acceptable safety profile. Future efforts should be directed at SASS implementation at the health service level.
Trial Registration:
anzctr.org.au Identifier: ACTRN12620000783921.
Related Concept Videos
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pre-Procedural Guidelines for Assessing Blood Pressure

